AstraZeneca Plc
Q4 2022 Earnings Call
Feb 09, 2023, 6:45 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Good morning to those joining from the U.K. and the U.S. Good afternoon to those in Central Europe. And good evening to those listening in Asia.
Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2022 results conference call for investors and analysts. Before I hand the call over to AstraZeneca, I'd like to read the safe harbor statement. The company intends to utilize the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.
Although we believe our expectations are based on reasonable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Any forward-looking statements made on the call reflect the knowledge and information available at the time of this call. The company undertakes no obligation to update forward-looking statements. Please also carefully review the forward-looking statements disclaimer in the slide deck that accompanies this call.
There will be an opportunity to ask questions after today's presentations. [Operator instructions] I must advise that this conference is being recorded today. And with that, I will now hand you over to the company.
Andy Barnett -- Head of Investor Relations
Thank you, operator, and good afternoon, everyone. I'm Andy Barnett, head of investor relations at AstraZeneca, and I'm pleased to welcome you to AstraZeneca's fourth-quarter and full-year conference call for 2022. We will also present our guidance for 2023 on today's call. As usual, all materials presented are available on our website.
Please advance to Slide 2. This slide contains our usual safe harbor statement where we're making comments on our performance using constant exchange rates, or CER, core financial numbers, and other non-GAAP measures. A non-GAAP to GAAP reconciliation is contained within our results announcement. Numbers are in million U.S.
dollars unless otherwise stated. Please advance to the next slide. This slide shows the agenda for today's call. Following our prepared remarks, we will open the side for questions.
We will try to address as many questions as we can during the allotted time, although I would ask that participants limit the number of questions you ask to allow a fair chance for others to participate in the Q&A. As a reminder to ask a question, please use the raised hand function in Zoom. Alternatively, you can click the Q&A button and write your question online. Please advance to the next slide.